logo

Stock Market Close, July 9, 2026: Markets Stage Partial Rebound from Previous Session’s Crash as Realty Stocks Lead Rise

Authored By HDFC SKY | Published at: Jul 9, 2026 04:36 PM IST

Stock Market Close, July 9, 2026: Markets Stage Partial Rebound from Previous Session’s Crash as Realty Stocks Lead Rise
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Mumbai, July 9: Indian benchmark indices ended higher on Thursday after a volatile trading session, with investors returning to beaten-down stocks following the previous day’s sharp sell-off. Broad-based buying in realty, PSU banks and consumer-focused sectors helped offset weakness in information technology shares, while broader markets significantly outperformed the benchmarks.

The BSE Sensex rose 238.22 points, or 0.31%, to close at 76,741.82, while the NSE Nifty50 gained 80.75 points, or 0.34%, to settle at 23,962.80, ending above the 23,950 mark. Market breadth remained firmly positive, with 2,793 stocks advancing, 1,263 declining and 167 remaining unchanged on the NSE.

Realty Leads Sectoral Gains

Buying was visible across most sectors, with the Nifty Realty index emerging as the biggest gainer, surging 3.5%. The rally was followed by the Nifty Media index, which climbed 2%, while the Nifty PSU Bank and Nifty Consumer Durables indices advanced 1.6% each.

In contrast, technology stocks remained under pressure ahead of the start of the June-quarter earnings season. The Nifty IT index fell 0.47%, while the Nifty Auto index slipped 0.25%.

Sensex edged up at the close after paring gains. Source: BSE

Sensex edged up at the close after paring gains. Source: BSE

The broader market outperformed the frontline indices, with the Nifty Midcap 100 rising 1.4% and the Nifty Smallcap 100 gaining 1.8%, indicating strong participation beyond the benchmark stocks.

Sun Pharma, Bharti Airtel Among Top Gainers

Among the Nifty50 constituents, Sun Pharma topped the gainers’ list with a 2.6% rise. Bharti Airtel gained 2.2%, followed by InterGlobe Aviation and Eternal, which rose about 2% each. Kotak Mahindra Bank also advanced 1.9%, lending support to the banking pack.

On the losing side, Dr Reddy’s Laboratories tumbled 5.9% after the company delayed commercial supplies of its semaglutide product due to quality concerns related to its active pharmaceutical ingredient. Infosys fell 1.7%, while Maruti Suzuki, NTPC and ONGC declined between 1.3% and 1.6%.

Markets Recover After Previous day’s Rout

Thursday’s gains marked a partial recovery after Indian equities suffered their steepest single-day decline in more than three months in the previous session, when rising crude oil prices and escalating geopolitical tensions in the Middle East triggered broad-based selling.

Nifty could not hold on to gains but managed to post partial recovery from yesterday’s crash at close. Source: NSE

Nifty could not hold on to gains but managed to post partial recovery from yesterday’s crash at close. Source: NSE

While Brent crude remained elevated near $79 per barrel, investors took advantage of lower valuations following Wednesday’s correction, helping domestic equities rebound despite persistent concerns over inflation and the potential impact of higher oil prices on corporate earnings.

Market participants will now shift their attention to the June-quarter earnings season, beginning with Tata Consultancy Services (TCS), while continuing to monitor developments in the Middle East and movements in crude oil prices for further cues.

Source:

  • NSE
  • BSE
Disclaimer
At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please Note: The information shared is intended solely for informational purposes and does not make any investment recommendations
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Sector: Pharmaceuticals & Biotechnology

SUNPHARMA Share Price

Sun Pharmaceutical Industries Ltd.

₹1,940.70

52.50(2.78%)
No Graph
1 Year Returns:-
13.30%
Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy